Erythrina plants, locally known as "dadap ayam", are higher plant species and have been used as a folk medicine for treatment of cancer. To prove the effectiveness of the leaves and stem bark of E. variegata as an anti-cancer agent, the assay in this research was focused on in vitro test towards breast cancer cell T47D. In the course of our continuing search for novel anti-cancer agent from Erythrina plants, the methanol extract of the leaves and stem bark of E. variegata showed significant anti-cancer activity against breast cancer cell T47D in vitro using the Sulphorhodamine B (SRB) assay. By using the anti-cancer activity to follow the separations, the methanol extract was separated by combination of column chromatography. The chemical structure of an anti-cancer compounds were determined on the basis of spectroscopic evidence and comparison with the previously reported and identified as an erythrina alkaloid (1) and isoflavonoid (2). Compounds (1-2) showed anti-cancer activity against breast cancer cell T47D used with IC50 of 1.0 and 3.3 µg/mL, respectively. This results strongly suggested that E. variegata is promising sources for anti-cancer agents.
INTRODUCTION
Breast cancer is the most commonly diagnosed invasive non-skin malignancy and second leading cause (after lung cancer) of cancer related deaths in the women. Both epidemiological and laboratory studies show that environmental and behavioral factors are more important than genetic factors in determining overall cancer frequency among populations. Currently, systemic cytotoxic chemotherapy approaches, controlling and treating breast cancer, are being used; which are not only less effective but are also nonselective and highly toxic to normal tissues (Tyagi et al., 2004) . Cisplatin is an anticancer drug that has enjoyed remarkable success against testicular tumor, but dose limiting side-effects have limited its application against a broader range of cancer. An approach that is gaining attention in recent years is combination chemotherapy, where nontoxic or less toxic phytochemicals are being combined with chemotherapy agents to enhance the efficacy together with a reduced toxicity to normal tissues (Tyagi et al., 2002) .
The search for anti-cancer medicinal plant depends on the accurate and specific ethno-botanical and ethno-pharmacological information obtained from the reference document. Recently, attention was focused on medicinal plants to provide new anticancer agents. E. variegata (Leguminosae) is a famous medicinal plant widely distributed in tropical and subtropical region of the world. This plant is locally known as "dadap ayam" in Indonesia and the leaves of E. variegata are used as an anti-cancer agent (Heyne, 1987) .
Previous studies have shown that the leaves of E. variegata contains alkaloids and flavonoids, which are unknown to display interesting biological activities (Chawla et al., 1987; Tanaka et al., 1988; 2003; Herlina et al., 2008) .
*Corresponding author e-mail: tata_04her@yahoo.com Herlina, et al., 2011 Indones. J. Cancer Chemoprevent., 2(3) , [286] [287] [288] [289] [290] Pharmacological report that steroid derivates from the stem bark and the leaves of E. variegata showed an anti-cancer against on breast cancer cell T47D in vitro (Herlina, 2009) . As part of our continuing search for novel anti-cancer compound from Indonesia Erythrina plants, we report here with the isolation, structure elucidation and anti-cancer activity.
MATERIALS AND METHODS

General Experimental Procedure
Melting points were uncorrected. The IR spectra were recorded with a Perkin-Elmer 1760 X FT-IR spectrophotometer, and the UV spectra were recorded with a Hitachi model U-3210. Mass spectra were recorded with JEOL JMS-DX300 instrument. The 1 H-and 13 C-NMR spectra were obtained with JEOL JNM GX 270 and JNM A-500 spectrometer. Chemical shifts are given on a δ (ppm) scale with TMS as an internal standard. Column chromatography was carried out using Merck Kieselgel 60 (70-200 mesh), and thin layer chromatography (TLC) analysis was performed on precoated Si Gel plates (Merck Kieselgel GF 254 , 0.25 mm 20 x 20 cm).
Plant material
Samples of the stem bark and the leaves of E. variegata was collected on June 2008, in Bandung District, West Java, Indonesia. The plant was identified by a staff at the Laboratory of Plant Taxonomy, Department of Biology, Bandung Institute of Technology, Bandung, Indonesia, and a voucher specimen has been deposited at the herbarium.
Anti-cancer Assay
National Cancer Institute developed an in vitro anticancer-drug method with the SRB (Sulforhodamine B) assay. This method measures the cellular protein content of adherent and suspension cultures in 96-well microtiter plates. Cultures fixed with trichloro acetic acid (TCA) are stained with 0.4% SRB dissolved in 1% acetic acid. Unbounded dye is removed by washing with 1% acetic acid, and protein-bound dye is extracted with 10 mM buffered tris base [tris (hydroxymethyl) amino methane] for the determination of optical density (515 nm) with a 96-well microtiter plate reader. Cisplatin functioned well as positive controls (Skehan et al., 1990) .
Extraction and isolation
The dried leaves (2 kg) of E. variegata were soaked in MeOH. Evaporation of the MeOH gave an aqueous concentrate, which was extracted with CH 2 Cl 2 . The resulting CH 2 Cl 2 extract was partitioned between n-hexane and MeOH containing 10% water, and then the lower layer was concentrated and extracted with EtOAc to efford residue (36.31 g). The methanol layer was partitioned between n-butanol-water (3:1). The nbutanol layer was subsequently dried over anhydrous sodium sulfate, filtered, evaporated to dryness, and assayed for anti-malarial activity. The n-butanol fraction (4 g) was chromatographed on Kieselgel 60 (70-230 mesh) by eluting with chloroform-ethyl acetate in an increasing ratio (1:1-1:5) to yield a 3 fractions (BA, BB, and BC). The BC fraction (1.5 g) was eluted with chloroform and 5% acetic acid were further flashchromatographed on Kieselgel 60 to yield an isolate 1 (53 mg).
The dried stem bark (2.2 kg) of E. variegata was extracted by maceration technique three times with methanol. The crude methanolic extract was then assayed for antimalarial activity via the LDH method. Evaporation of the methanol extract gave concentrated aqueous extract, which was extracted with dichloromethane. The resulting dichloromethane extract was partitioned between n-hexane and methanol containing 10% water, and then lower layer was concentrated and extracted with ethyl acetate. The ethyl acetate layer was subsequently dried over anhydrous sodium sulfate, filtered, evaporated to dryness, and assayed for anti-malarial activity. The ethyl acetate fraction (15.8 g) was chromatographed on Kieselgel 60 (70-230 mesh) by eluting with n-hexane and an increasing ratio of ethyl acetate, and by ethyl acetate and an increasing ratio of methanol to afford the 20% methanol eluate (1.2 g). The fraction (683 mg) eluted with 10% and 20% methanol were further flash-chromatographed on Kieselgel 60 with 5% methanol in chloroform to yield a crude active compound (191 mg), which were crystallized from methanol to yield active compounds (21.3 mg) and 2 (25.5 mg).
RESULTS AND DISCUSSION
The methanolic extract of dried of the leaves and stem bark of E. variegata exhibited an anti-cancer activity against breast cancer T47D cell in vitro using the SRB method. The active methanol extract was partitioned between nhexane, ethyl acetate, and n-butanol to afford an active ethyl acetate and n-butanol. By using the SRB method to follow the separations, the ethyl acetate and n-butanol fraction were separated by combination of column chromatography on Kieselgel 60 to afford a two active isolates (1 and 2).
The Fig.1 .
Anti-cancer activity of extract, fraction, and isolates
The percentage inhibition of methanol extract, ethyl acetate, n-butanol fraction and, isolates (1 and 2) against breast cancer cell T47D can be described to be in the following that isolate 1 (IC 50 1.0 µg/mL) higher than isolate 2, n-butanol fraction (IC 50 10.5 µg/mL), ethyl acetate fraction (IC 50 22.9 µg/mL), and methanol extract (IC 50 43.7µg/mL) ( Table I) . Fig. 1 . The NOESY spectra showed signals assignable to α-configurated equatorial of H-1, H-2, H-3, H-4, H-7, and H-8, while of 2-OH, 3-OCH 3, , and H-17 are β-configurated axial. The based on the spectral spectroscopic evidence, comparison with the previously reported and biogenetic point of view, the genus Erythrina seems to lack biogenetic ability to produce alkaloids (Chawla et al, 1987; Supratman et al., 2002) (2H, H-1") ; δc 22.6, δ H 5.31 (1H, H-2'); δc 121.9, δ H 5.27 (1H, H-2"); δc 122.1], respectively, indicating that 2 to be pterocarpan derivative having two isoprenyl groups. The HMBC spectra of 2 showed correlations proton H-4 (δ H 6.38) with C-2 (δ C 121.6), between proton H-1' (δ H 29.4) with C-2 (δ C 121.6) and C-3 (δ C 155.7), between proton H-6ax (δ H 3.90) with C-4a (δ C 154.2) and C-11a (δ C 158.6), and proton H-8 (δ H 6.49) with C-6b (δ C 120.6), respectively, indicating the position of hydroxyl groups at C-3 and C-6a. The correlation proton H-8 (δ H 6.49) with C-9 (δ C 159.9), indicating that methoxyl group at position C-9. Furthermore the correlation between proton H-1' (δ H 3.30) with C-1 (δ C 132.2) and C-2 (δ C 121.6), and H-1" (δ H 3.20) with C-10 (δ C 113.7), indicating the position of isoprenyl groups at C-2 and C-10. The HMBC and 1 H-1 H COSY spectra of isolate 2 are illustrated in Fig.1 . These observations together with a detailed comparison of there spectral data with those previously reported led us to identify the isolate 2 as erystagallin A (Tanaka et al., 1988) .
The potency of methanol extract, ethyl acetate fraction, and 10,11-dioxoerythratidine against breast cancer T47D cell can be described to be in the following order; 10,11-dioxoerythratidine > erystagallin A > n-butanol fraction > ethyl acetate fraction > methanol extract, indicated that 10,11-dioxoerythratidine and erystagallin A to be potential as an anti-cancer agents.
CONCLUSION
The 10,11-dioxoerythratidine (1) and the crystagallin A (2) had been isolated from the leaves and stem bark of E. variegata. Our results strongly suggested that both compounds (1-2) are promising as anti-cancer agents.
